Home Endocyte's ovarian cancer drug fails trial, shares sink
 

Keywords :   


Endocyte's ovarian cancer drug fails trial, shares sink

2014-05-04 10:59:52| Biotech - Topix.net

Merck & Co Inc and Endocyte Inc said they had stopped a late-stage trial of their experimental ovarian cancer drug as it failed to improve survival rates without the cancer worsening, sending Endocyte's shares tumbling as much as 63 percent.

Tags: trial drug cancer shares

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.11 HEXAGON TR SET UP
28.1121dc hg
28.111EX D
28.11 Bucchus IMP24 FMH-RSM/M
28.11
28.11specialites TA carmina 46-36
28.11HUNTER×HUNTER
28.11
More »